GeoVax Labs, Inc. (GOVX)
GOVX Stock Price Chart
Explore GeoVax Labs, Inc. interactive price chart. Choose custom timeframes to analyze GOVX price movements and trends.
GOVX Company Profile
Discover essential business fundamentals and corporate details for GeoVax Labs, Inc. (GOVX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Sept 2020
Employees
17.00
Website
https://www.geovax.comCEO
David Alan Dodd
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
GOVX Financial Timeline
Browse a chronological timeline of GeoVax Labs, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.24.
Earnings released on 28 Jul 2025
EPS came in at -$0.35 surpassing the estimated -$0.41 by +14.63%, while revenue for the quarter reached $852.28K , beating expectations by +9.82%.
Earnings released on 1 May 2025
EPS came in at -$0.45 surpassing the estimated -$0.59 by +23.73%, while revenue for the quarter reached $1.64M , beating expectations by +346.41%.
Earnings released on 27 Mar 2025
EPS came in at -$0.30 surpassing the estimated -$0.79 by +62.03%, while revenue for the quarter reached $864.42K , missing expectations by -63.68%.
Earnings released on 12 Nov 2024
EPS came in at -$0.91 surpassing the estimated -$1.29 by +29.46%, while revenue for the quarter reached $2.79M , beating expectations by +203.20%.
Earnings released on 6 Aug 2024
EPS came in at -$1.99 surpassing the estimated -$2.57 by +22.57%, while revenue for the quarter reached $300.68K .
Earnings released on 14 May 2024
EPS came in at -$2.47 surpassing the estimated -$5.56 by +55.58%.
Earnings released on 29 Feb 2024
EPS came in at -$13.60 falling short of the estimated -$2.78 by -389.21%, while revenue for the quarter reached $103.91K .
Stock split effective on 31 Jan 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -$4.80 falling short of the estimated -$2.55 by -88.24%.
Earnings released on 9 Aug 2023
EPS came in at -$3.30 falling short of the estimated -$2.40 by -37.50%.
Earnings released on 4 May 2023
EPS came in at -$2.25 surpassing the estimated -$2.85 by +21.05%.
Earnings released on 23 Mar 2023
EPS came in at -$3.00 falling short of the estimated -$2.55 by -17.65%, while revenue for the quarter reached -$81.53K .
Earnings released on 9 Nov 2022
EPS came in at -$2.55 falling short of the estimated -$1.80 by -41.67%.
Earnings released on 3 Aug 2022
EPS came in at -$2.70 falling short of the estimated -$0.32 by -743.75%.
Earnings released on 27 Apr 2022
EPS came in at -$5.10 falling short of the estimated -$0.31 by -1.55K%, while revenue for the quarter reached $81.53K .
Earnings released on 9 Mar 2022
EPS came in at -$33.58 falling short of the estimated -$0.40 by -8.29K%, while revenue for the quarter reached $164.96K .
Earnings released on 11 Nov 2021
EPS came in at -$4.65 falling short of the estimated -$0.37 by -1.16K%, while revenue for the quarter reached $30.41K .
Earnings released on 11 Aug 2021
EPS came in at -$3.15 falling short of the estimated -$0.43 by -632.56%, while revenue for the quarter reached $79.71K , missing expectations by -27.54%.
Earnings released on 6 May 2021
EPS came in at -$4.35 , while revenue for the quarter reached $110.42K .
Earnings released on 23 Mar 2021
EPS came in at -$1.15 falling short of the estimated -$0.04 by -2.77K%, while revenue for the quarter reached $251.62K .
Earnings released on 5 Nov 2020
EPS came in at -$10.94 , while revenue for the quarter reached $415.46K .
Stock split effective on 25 Sept 2020
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
GOVX Stock Performance
Access detailed GOVX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.